Showing 1 - 9 results of 9 for search 'Hiddo J. L. Heerspink', query time: 0.08s Refine Results
  1. 1
    Progress and opportunities in measuring the burden of Chronic Kidney Disease

    Progress and opportunities in measuring the burden of Chronic Kidney Disease by Priya Vart, Hiddo J.L. Heerspink

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Kinetics of endothelin-1 and effect selective ETA antagonism on ETB activation: a mathematical modeling analysis

    Kinetics of endothelin-1 and effect selective ETA antagonism on ETB activation: a mathematical modeling analysis by K. Melissa Hallow, K. Melissa Hallow, Peter J. Greasley, Hiddo J. L. Heerspink, Hiddo J. L. Heerspink, Hongtao Yu

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Prediction of the Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Based on Short-Term Changes in Multiple Risk Markers

    Prediction of the Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Based on Short-Term Changes in Multiple Risk Markers by Sok Cin Tye, Sieta T. de Vries, Christoph Wanner, Petra Denig, Hiddo J. L. Heerspink

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Precision medicine in regulatory decision making: Biomarkers used for patient selection in European Public Assessment Reports from 2018 to 2020

    Precision medicine in regulatory decision making: Biomarkers used for patient selection in European Public Assessment Reports from 2018 to 2020 by Elisabeth Bakker, Viktoriia Starokozhko, Jet W. M. Kraaijvanger, Hiddo J. L. Heerspink, Peter G. M. Mol

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    A Review of the Dose Justification of Phase 3 Trials to Regulatory Authorities for Drugs Intended for the Treatment of Type 2 Diabetes in Europe

    A Review of the Dose Justification of Phase 3 Trials to Regulatory Authorities for Drugs Intended for the Treatment of Type 2 Diabetes in Europe by Jeroen V. Koomen, Jeroen V. Koomen, Jasper Stevens, Margje H. Monster-Simons, Margje H. Monster-Simons, Hiddo J. L. Heerspink, Peter G. M. Mol, Peter G. M. Mol

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Prediction of the Effects of Liraglutide on Kidney and Cardiovascular Outcomes Based on Short-Term Changes in Multiple Risk Markers

    Prediction of the Effects of Liraglutide on Kidney and Cardiovascular Outcomes Based on Short-Term Changes in Multiple Risk Markers by Sok Cin Tye, Sieta T. de Vries, Johannes F. E. Mann, Johannes F. E. Mann, Meir Schechter, Meir Schechter, Ofri Mosenzon, Ofri Mosenzon, Petra Denig, Hiddo J. L. Heerspink

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Plasma Nitrate Levels Are Related to Metabolic Syndrome and Are Not Altered by Treatment with DPP-4 Inhibitor Linagliptin: A Randomised, Placebo-Controlled Trial in Patients with Early Type 2 Diabetes Mellitus

    Plasma Nitrate Levels Are Related to Metabolic Syndrome and Are Not Altered by Treatment with DPP-4 Inhibitor Linagliptin: A Randomised, Placebo-Controlled Trial in Patients with E... by Melanie Reijrink, Stefanie A. De Boer, Anniek M. Van Roon, Riemer H. J. A. Slart, Bernadette O. Fernandez, Martin Feelisch, Hiddo J. L. Heerspink, Harry Van Goor, Jan-Luuk Hillebrands, Douwe J. Mulder

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    Adherence to Statin Therapy and Attainment of LDL Cholesterol Targets in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente (DIALECT)

    Adherence to Statin Therapy and Attainment of LDL Cholesterol Targets in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente... by Jelle M. Beernink, Milou M. Oosterwijk, Job F. M. van Boven, Job F. M. van Boven, Hiddo J. L. Heerspink, Stephan J. L. Bakker, Stephan J. L. Bakker, Gerjan Navis, Roos M. Nijboer, Christina M. Gant, Christina M. Gant, Heleen Haverkate, Willemien J. Kruik-Kollöffel, Gozewijn D. Laverman, Gozewijn D. Laverman

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  9. 9
    Perspectives on a Way Forward to Implementation of Precision Medicine in Patients With Diabetic Kidney Disease; Results of a Stakeholder Consensus-Building Meeting

    Perspectives on a Way Forward to Implementation of Precision Medicine in Patients With Diabetic Kidney Disease; Results of a Stakeholder Consensus-Building Meeting by Elisabeth Bakker, Peter G. M. Mol, Peter G. M. Mol, Peter G. M. Mol, João Nabais, João Nabais, Thorsten Vetter, Matthias Kretzler, John J. Nolan, Gert Mayer, Anna K. Sundgren, Hiddo J. L. Heerspink, Anja Schiel, Anja Schiel, Sieta T. de Vries, Maria F. Gomez, Friedrich Schulze, Dick de Zeeuw, Michelle J. Pena, for the BEAt-DKD Consortium

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: